Carlsmed (CARL) Competitors $13.01 -0.88 (-6.34%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsSEC FilingsShort InterestTrendsBuy This Stock CARL vs. CNMD, ESTA, BLFS, KMTS, PLSE, TNDM, MDXG, IRMD, INMD, and BBNXShould you be buying Carlsmed stock or one of its competitors? The main competitors of Carlsmed include CONMED (CNMD), Establishment Labs (ESTA), BioLife Solutions (BLFS), Kestra Medical Technologies (KMTS), Pulse Biosciences (PLSE), Tandem Diabetes Care (TNDM), MiMedx Group (MDXG), iRadimed (IRMD), InMode (INMD), and Beta Bionics (BBNX). These companies are all part of the "medical equipment" industry. Carlsmed vs. Its Competitors CONMED Establishment Labs BioLife Solutions Kestra Medical Technologies Pulse Biosciences Tandem Diabetes Care MiMedx Group iRadimed InMode Beta Bionics CONMED (NYSE:CNMD) and Carlsmed (NASDAQ:CARL) are both small-cap medical equipment companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, earnings, risk, profitability, analyst recommendations, institutional ownership, media sentiment and dividends. Is CNMD or CARL more profitable? CONMED has a net margin of 8.31% compared to Carlsmed's net margin of 0.00%. CONMED's return on equity of 14.43% beat Carlsmed's return on equity.Company Net Margins Return on Equity Return on Assets CONMED8.31% 14.43% 6.05% Carlsmed N/A N/A N/A Do analysts rate CNMD or CARL? CONMED currently has a consensus target price of $59.80, suggesting a potential upside of 24.20%. Given CONMED's stronger consensus rating and higher possible upside, equities research analysts clearly believe CONMED is more favorable than Carlsmed.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CONMED 1 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00Carlsmed 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Which has stronger valuation & earnings, CNMD or CARL? CONMED has higher revenue and earnings than Carlsmed. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCONMED$1.31B1.14$132.42M$3.5313.64Carlsmed$27.17M12.73N/AN/AN/A Does the media refer more to CNMD or CARL? In the previous week, Carlsmed had 3 more articles in the media than CONMED. MarketBeat recorded 4 mentions for Carlsmed and 1 mentions for CONMED. CONMED's average media sentiment score of 1.54 beat Carlsmed's score of 0.00 indicating that CONMED is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CONMED 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Carlsmed 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryCONMED beats Carlsmed on 8 of the 10 factors compared between the two stocks. Get Carlsmed News Delivered to You Automatically Sign up to receive the latest news and ratings for CARL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CARL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CARL vs. The Competition Export to ExcelMetricCarlsmedSurgical, Medical, And Dental Instruments And Supplies IndustryManufacturing SectorNASDAQ ExchangeMarket Cap$345.81M$182.06M$2.53B$10.67BDividend YieldN/AN/A2.49%4.86%P/E RatioN/A2.0321.9228.52Price / Sales12.734.64109.24129.07Price / CashN/A4.0343.6061.42Price / BookN/A1.5633.656.52Net IncomeN/A-$51.31M$6.87M$276.75M7 Day Performance-4.55%-2.89%0.35%0.21%1 Month Performance-9.84%-6.95%-0.29%1.68%1 Year PerformanceN/A292.59%94.53%32.79% Carlsmed Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CARLCarlsmedN/A$13.01-6.3%N/AN/A$345.81M$27.17M0.00100News CoveragePositive NewsShort Interest ↑CNMDCONMED4.7888 of 5 stars$45.11+0.3%$59.80+32.6%-22.5%$1.39B$1.31B12.783,900Positive NewsESTAEstablishment Labs1.793 of 5 stars$47.26+1.4%$56.50+19.6%+10.4%$1.35B$166.02M-15.501,018BLFSBioLife Solutions2.3455 of 5 stars$27.32-1.5%$31.29+14.5%+21.8%$1.33B$82.25M-227.65440Positive NewsKMTSKestra Medical Technologies0.7704 of 5 stars$24.61+5.8%$27.33+11.1%N/A$1.20B$59.81M0.00300PLSEPulse Biosciences3.5487 of 5 stars$17.56-0.1%$22.00+25.3%-2.2%$1.18B$700K-16.72140Upcoming EarningsTNDMTandem Diabetes Care4.1901 of 5 stars$14.79-3.3%$22.19+50.0%-55.4%$1.03B$940.20M-4.792,650Analyst ForecastMDXGMiMedx Group3.1851 of 5 stars$6.69+0.9%$12.00+79.4%+17.5%$980.97M$348.88M31.86870News CoveragePositive NewsUpcoming EarningsIRMDiRadimed4.679 of 5 stars$73.43-3.4%$72.00-1.9%+52.3%$966.98M$73.24M45.33110News CoverageUpcoming EarningsInsider TradeINMDInMode3.0027 of 5 stars$15.31+0.6%$16.85+10.1%-15.0%$962.04M$394.82M6.20480BBNXBeta Bionics3.2634 of 5 stars$20.02-3.0%$24.44+22.1%N/A$896.79M$65.12M0.00294Analyst ForecastShort Interest ↑ Related Companies and Tools Related Companies CNMD Competitors ESTA Competitors BLFS Competitors KMTS Competitors PLSE Competitors TNDM Competitors MDXG Competitors IRMD Competitors INMD Competitors BBNX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CARL) was last updated on 10/23/2025 by MarketBeat.com Staff From Our PartnersRobinhood warningA strange chasm is coming to Wall Street... It's already creating millionaires and billionaires at the fast...Stansberry Research | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored7 market signals flashing red right nowRight now, the same 7 key indicators that predicted 1929, the 1970s stagflation, and the 2008 meltdown are all...American Alternative | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Carlsmed, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Carlsmed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CARL Stock Alerts